| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colonic Neoplasms | 31 | 2014 | 578 | 4.130 |
Why?
|
| ErbB Receptors | 10 | 2014 | 504 | 2.190 |
Why?
|
| Colitis | 10 | 2014 | 260 | 1.520 |
Why?
|
| Ursodeoxycholic Acid | 6 | 2010 | 26 | 1.280 |
Why?
|
| Isoenzymes | 17 | 2003 | 271 | 1.170 |
Why?
|
| Protein Kinase C | 21 | 2012 | 260 | 1.150 |
Why?
|
| Azoxymethane | 18 | 2011 | 84 | 1.060 |
Why?
|
| Colon | 23 | 2013 | 540 | 1.030 |
Why?
|
| Receptors, Calcitriol | 7 | 2014 | 130 | 0.940 |
Why?
|
| Cyclooxygenase 2 | 8 | 2010 | 99 | 0.910 |
Why?
|
| Calcitriol | 17 | 2007 | 173 | 0.900 |
Why?
|
| Down-Regulation | 9 | 2013 | 523 | 0.880 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2014 | 456 | 0.710 |
Why?
|
| Colorectal Neoplasms | 9 | 2014 | 1054 | 0.710 |
Why?
|
| Apoptosis | 11 | 2014 | 1719 | 0.690 |
Why?
|
| Gene Expression Regulation, Neoplastic | 12 | 2011 | 1339 | 0.670 |
Why?
|
| Genes, ras | 7 | 2008 | 97 | 0.660 |
Why?
|
| Cell Proliferation | 10 | 2014 | 1732 | 0.660 |
Why?
|
| Cyclin D1 | 8 | 2008 | 85 | 0.660 |
Why?
|
| Adenocarcinoma | 7 | 2011 | 1171 | 0.650 |
Why?
|
| Precancerous Conditions | 4 | 2012 | 204 | 0.570 |
Why?
|
| Colitis, Ulcerative | 4 | 2013 | 800 | 0.540 |
Why?
|
| MicroRNAs | 3 | 2011 | 581 | 0.540 |
Why?
|
| Benzenesulfonates | 2 | 2008 | 49 | 0.540 |
Why?
|
| Caco-2 Cells | 13 | 2012 | 125 | 0.530 |
Why?
|
| Paramyxovirinae | 2 | 2008 | 2 | 0.530 |
Why?
|
| Membrane Fusion | 2 | 2008 | 37 | 0.520 |
Why?
|
| beta Catenin | 7 | 2012 | 265 | 0.490 |
Why?
|
| Intestinal Mucosa | 12 | 2014 | 825 | 0.480 |
Why?
|
| Pyridines | 2 | 2008 | 302 | 0.480 |
Why?
|
| Tetradecanoylphorbol Acetate | 9 | 2006 | 121 | 0.470 |
Why?
|
| Dextran Sulfate | 6 | 2013 | 70 | 0.470 |
Why?
|
| Signal Transduction | 15 | 2014 | 3497 | 0.460 |
Why?
|
| Cholecalciferol | 3 | 2007 | 35 | 0.450 |
Why?
|
| Animals | 52 | 2014 | 27973 | 0.450 |
Why?
|
| Rats | 31 | 2012 | 4028 | 0.450 |
Why?
|
| Receptor Cross-Talk | 1 | 2014 | 32 | 0.430 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2014 | 7 | 0.410 |
Why?
|
| Renin-Angiotensin System | 1 | 2014 | 83 | 0.410 |
Why?
|
| Panax | 3 | 2014 | 171 | 0.410 |
Why?
|
| Plant Extracts | 2 | 2014 | 247 | 0.400 |
Why?
|
| Barrett Esophagus | 3 | 2012 | 94 | 0.380 |
Why?
|
| G1 Phase | 4 | 2011 | 64 | 0.370 |
Why?
|
| NF-kappa B | 5 | 2014 | 408 | 0.370 |
Why?
|
| Cell Line, Tumor | 10 | 2014 | 2757 | 0.360 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2003 | 36 | 0.360 |
Why?
|
| Esophageal Neoplasms | 3 | 2012 | 343 | 0.360 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 3 | 2012 | 121 | 0.350 |
Why?
|
| Viral Fusion Proteins | 2 | 2008 | 10 | 0.350 |
Why?
|
| Stromal Cells | 1 | 2012 | 152 | 0.340 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 2 | 2008 | 14 | 0.340 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2009 | 117 | 0.340 |
Why?
|
| Proto-Oncogenes | 1 | 2011 | 60 | 0.340 |
Why?
|
| Antineoplastic Agents | 4 | 2014 | 2301 | 0.330 |
Why?
|
| Dietary Fats | 1 | 2011 | 134 | 0.330 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2011 | 69 | 0.330 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2011 | 44 | 0.330 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2011 | 156 | 0.330 |
Why?
|
| Mice | 19 | 2014 | 12230 | 0.320 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2011 | 78 | 0.320 |
Why?
|
| Up-Regulation | 6 | 2013 | 727 | 0.310 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2009 | 49 | 0.310 |
Why?
|
| Cell Division | 7 | 2007 | 689 | 0.300 |
Why?
|
| Rats, Inbred F344 | 11 | 2008 | 160 | 0.300 |
Why?
|
| Calcium | 8 | 2012 | 1173 | 0.290 |
Why?
|
| Disease Models, Animal | 9 | 2014 | 2479 | 0.280 |
Why?
|
| Lithocholic Acid | 1 | 2008 | 2 | 0.280 |
Why?
|
| Blotting, Western | 7 | 2011 | 774 | 0.280 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2014 | 177 | 0.280 |
Why?
|
| Diet | 1 | 2011 | 461 | 0.270 |
Why?
|
| Carcinogens | 4 | 2007 | 101 | 0.260 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2008 | 216 | 0.260 |
Why?
|
| Protein Kinase C-delta | 3 | 2006 | 29 | 0.260 |
Why?
|
| Transcriptome | 1 | 2013 | 762 | 0.260 |
Why?
|
| Humans | 50 | 2014 | 93132 | 0.260 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2008 | 453 | 0.250 |
Why?
|
| Mutation | 9 | 2008 | 4265 | 0.240 |
Why?
|
| Collagen Type I | 1 | 2006 | 74 | 0.240 |
Why?
|
| Inflammation | 2 | 2012 | 1049 | 0.240 |
Why?
|
| Transfection | 5 | 2012 | 877 | 0.220 |
Why?
|
| Chemoprevention | 4 | 2010 | 93 | 0.220 |
Why?
|
| Adenoma | 2 | 2007 | 258 | 0.220 |
Why?
|
| Male | 35 | 2013 | 44355 | 0.210 |
Why?
|
| RNA, Messenger | 7 | 2011 | 2020 | 0.210 |
Why?
|
| Immunohistochemistry | 6 | 2013 | 1786 | 0.210 |
Why?
|
| Enzyme Activation | 14 | 2014 | 672 | 0.200 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 603 | 0.200 |
Why?
|
| HCT116 Cells | 3 | 2013 | 162 | 0.200 |
Why?
|
| Anticarcinogenic Agents | 5 | 2006 | 71 | 0.190 |
Why?
|
| Case-Control Studies | 3 | 2013 | 1925 | 0.190 |
Why?
|
| Cholagogues and Choleretics | 1 | 2002 | 10 | 0.190 |
Why?
|
| Cadherins | 2 | 2006 | 180 | 0.190 |
Why?
|
| Biomarkers, Tumor | 3 | 2011 | 1660 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 9 | 2013 | 3431 | 0.180 |
Why?
|
| Transcription Factors | 4 | 2014 | 1687 | 0.170 |
Why?
|
| Trans-Activators | 2 | 2002 | 439 | 0.170 |
Why?
|
| Mice, Knockout | 6 | 2014 | 2121 | 0.170 |
Why?
|
| Food-Processing Industry | 1 | 2001 | 3 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2008 | 151 | 0.170 |
Why?
|
| Food Preferences | 1 | 2001 | 27 | 0.170 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2013 | 296 | 0.170 |
Why?
|
| Cells, Cultured | 8 | 2012 | 2827 | 0.160 |
Why?
|
| Ginsenosides | 2 | 2012 | 124 | 0.160 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 4 | 2011 | 76 | 0.160 |
Why?
|
| Polyethylene Glycols | 3 | 2008 | 371 | 0.160 |
Why?
|
| Transforming Growth Factor beta | 1 | 2002 | 346 | 0.160 |
Why?
|
| Models, Psychological | 1 | 2001 | 164 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2000 | 94 | 0.160 |
Why?
|
| Transcription, Genetic | 2 | 2008 | 1114 | 0.150 |
Why?
|
| Adolescent Behavior | 1 | 2001 | 111 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2014 | 364 | 0.150 |
Why?
|
| Interleukin-1beta | 2 | 2012 | 88 | 0.150 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 1999 | 117 | 0.150 |
Why?
|
| Environment | 1 | 2001 | 230 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 12 | 2003 | 1236 | 0.140 |
Why?
|
| Cyclin E | 3 | 2008 | 28 | 0.140 |
Why?
|
| Snail Family Transcription Factors | 3 | 2014 | 47 | 0.140 |
Why?
|
| RNA, Small Interfering | 4 | 2010 | 556 | 0.140 |
Why?
|
| Genes, APC | 2 | 2011 | 25 | 0.140 |
Why?
|
| Reference Values | 4 | 2008 | 603 | 0.140 |
Why?
|
| Quinazolines | 3 | 2008 | 211 | 0.140 |
Why?
|
| Niacinamide | 2 | 2008 | 101 | 0.130 |
Why?
|
| STAT3 Transcription Factor | 2 | 2008 | 87 | 0.130 |
Why?
|
| Phenylurea Compounds | 2 | 2008 | 97 | 0.130 |
Why?
|
| Intestinal Neoplasms | 2 | 2011 | 68 | 0.130 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 2 | 2008 | 35 | 0.130 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2008 | 123 | 0.130 |
Why?
|
| Mice, Inbred A | 2 | 2007 | 21 | 0.130 |
Why?
|
| Type C Phospholipases | 1 | 1997 | 26 | 0.130 |
Why?
|
| Intracellular Membranes | 2 | 1994 | 112 | 0.130 |
Why?
|
| src-Family Kinases | 1 | 1997 | 70 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 6 | 2011 | 1022 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 2 | 2014 | 1385 | 0.120 |
Why?
|
| Cell Growth Processes | 2 | 2006 | 83 | 0.120 |
Why?
|
| Tight Junctions | 3 | 2013 | 154 | 0.120 |
Why?
|
| Neoplasms, Experimental | 2 | 2011 | 259 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2008 | 203 | 0.120 |
Why?
|
| Cyclins | 3 | 2008 | 80 | 0.120 |
Why?
|
| HT29 Cells | 3 | 2014 | 49 | 0.110 |
Why?
|
| Epithelial Cells | 6 | 2013 | 700 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2011 | 1908 | 0.110 |
Why?
|
| Kinetics | 9 | 1999 | 1463 | 0.110 |
Why?
|
| Cell Differentiation | 7 | 2014 | 1611 | 0.110 |
Why?
|
| Guanylate Cyclase | 4 | 1994 | 19 | 0.110 |
Why?
|
| Titanium | 1 | 2014 | 27 | 0.110 |
Why?
|
| Transcription Factor AP-1 | 2 | 2008 | 66 | 0.110 |
Why?
|
| Enteritis | 1 | 2014 | 23 | 0.100 |
Why?
|
| Angiotensin II | 1 | 2014 | 93 | 0.100 |
Why?
|
| Enzyme Inhibitors | 5 | 2006 | 638 | 0.100 |
Why?
|
| Telomere-Binding Proteins | 1 | 2014 | 14 | 0.100 |
Why?
|
| Telomere Homeostasis | 1 | 2014 | 28 | 0.100 |
Why?
|
| Disease Progression | 3 | 2012 | 1529 | 0.100 |
Why?
|
| Analysis of Variance | 3 | 2008 | 883 | 0.100 |
Why?
|
| Oligonucleotides | 1 | 2014 | 91 | 0.100 |
Why?
|
| Cell Nucleus | 2 | 2002 | 601 | 0.100 |
Why?
|
| Cholic Acid | 2 | 2008 | 8 | 0.100 |
Why?
|
| Cross-Sectional Studies | 2 | 2013 | 1849 | 0.090 |
Why?
|
| Base Sequence | 2 | 2008 | 2207 | 0.090 |
Why?
|
| Bradykinin | 1 | 1992 | 44 | 0.090 |
Why?
|
| DNA, Complementary | 1 | 2013 | 379 | 0.090 |
Why?
|
| Estrogen Receptor beta | 1 | 2012 | 26 | 0.090 |
Why?
|
| Female | 9 | 2014 | 48542 | 0.090 |
Why?
|
| Coculture Techniques | 1 | 2012 | 170 | 0.090 |
Why?
|
| Genetic Markers | 1 | 2013 | 469 | 0.090 |
Why?
|
| Peptide Hormones | 1 | 2012 | 30 | 0.090 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 2889 | 0.090 |
Why?
|
| Adipokines | 1 | 2011 | 18 | 0.090 |
Why?
|
| Lectins | 1 | 2011 | 82 | 0.080 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2011 | 43 | 0.080 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 371 | 0.080 |
Why?
|
| Phospholipase D | 3 | 1999 | 13 | 0.080 |
Why?
|
| Fatty Acids, Volatile | 1 | 2011 | 35 | 0.080 |
Why?
|
| Macrophages | 1 | 2014 | 609 | 0.080 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2012 | 67 | 0.080 |
Why?
|
| Cetuximab | 1 | 2011 | 118 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 691 | 0.080 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 303 | 0.080 |
Why?
|
| Cytoskeletal Proteins | 2 | 2002 | 222 | 0.080 |
Why?
|
| Butyrates | 1 | 2011 | 56 | 0.080 |
Why?
|
| Immunoprecipitation | 2 | 2011 | 136 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2012 | 353 | 0.080 |
Why?
|
| Vitamin D | 2 | 2007 | 272 | 0.080 |
Why?
|
| GTP-Binding Proteins | 3 | 1999 | 147 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2011 | 228 | 0.080 |
Why?
|
| Phosphatidylcholines | 2 | 1999 | 48 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2013 | 1517 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2012 | 468 | 0.080 |
Why?
|
| Dietary Supplements | 2 | 2008 | 130 | 0.080 |
Why?
|
| Phosphorylation | 5 | 2012 | 1129 | 0.080 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2013 | 647 | 0.080 |
Why?
|
| Splints | 1 | 1989 | 10 | 0.070 |
Why?
|
| Finger Injuries | 1 | 1989 | 12 | 0.070 |
Why?
|
| Carcinoma | 1 | 2012 | 439 | 0.070 |
Why?
|
| HN Protein | 1 | 2008 | 4 | 0.070 |
Why?
|
| Myosin-Light-Chain Kinase | 1 | 1989 | 38 | 0.070 |
Why?
|
| Tendon Injuries | 1 | 1989 | 39 | 0.070 |
Why?
|
| Point Mutation | 1 | 2009 | 237 | 0.070 |
Why?
|
| 3' Untranslated Regions | 1 | 2009 | 98 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2010 | 199 | 0.070 |
Why?
|
| Vero Cells | 1 | 2008 | 98 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase 2 | 2 | 2006 | 25 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase 6 | 2 | 2006 | 17 | 0.070 |
Why?
|
| Middle Aged | 5 | 2013 | 27535 | 0.070 |
Why?
|
| Cyclin D | 1 | 2008 | 15 | 0.070 |
Why?
|
| Microvilli | 1 | 1988 | 44 | 0.070 |
Why?
|
| Models, Molecular | 2 | 2012 | 1353 | 0.070 |
Why?
|
| Ligands | 1 | 2009 | 476 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 392 | 0.070 |
Why?
|
| Alkaline Phosphatase | 1 | 1988 | 128 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2011 | 941 | 0.070 |
Why?
|
| Clone Cells | 1 | 2008 | 219 | 0.070 |
Why?
|
| DNA Primers | 1 | 2008 | 528 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 451 | 0.070 |
Why?
|
| HeLa Cells | 1 | 2008 | 517 | 0.070 |
Why?
|
| Bacteria | 1 | 2011 | 508 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2014 | 1276 | 0.070 |
Why?
|
| Pancreas | 1 | 1989 | 256 | 0.060 |
Why?
|
| Kidney | 1 | 1992 | 1093 | 0.060 |
Why?
|
| Insulin Resistance | 1 | 2009 | 379 | 0.060 |
Why?
|
| Phosphoric Diester Hydrolases | 3 | 1997 | 23 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 726 | 0.060 |
Why?
|
| Probability | 1 | 2008 | 352 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 1 | 2008 | 570 | 0.060 |
Why?
|
| Protein Biosynthesis | 1 | 2009 | 372 | 0.060 |
Why?
|
| Cell Line | 3 | 2009 | 2458 | 0.060 |
Why?
|
| Hypertension | 1 | 1992 | 748 | 0.060 |
Why?
|
| Models, Biological | 3 | 2008 | 1768 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2007 | 200 | 0.060 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2006 | 54 | 0.060 |
Why?
|
| Cholesterol | 1 | 1988 | 364 | 0.060 |
Why?
|
| Intestine, Small | 1 | 1988 | 311 | 0.060 |
Why?
|
| Loss of Heterozygosity | 1 | 2006 | 84 | 0.060 |
Why?
|
| Viral Plaque Assay | 1 | 2006 | 17 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2010 | 916 | 0.060 |
Why?
|
| Cell Fusion | 1 | 2006 | 34 | 0.060 |
Why?
|
| Giant Cells | 1 | 2006 | 18 | 0.060 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 1060 | 0.060 |
Why?
|
| Erythrocyte Membrane | 1 | 2006 | 60 | 0.060 |
Why?
|
| Time Factors | 4 | 2009 | 5380 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2009 | 866 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2013 | 298 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 215 | 0.060 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2011 | 1000 | 0.060 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 1994 | 0.060 |
Why?
|
| Gene Expression | 2 | 2002 | 1304 | 0.060 |
Why?
|
| Cell Adhesion | 1 | 2006 | 416 | 0.060 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2006 | 162 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2014 | 688 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2006 | 479 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2007 | 353 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2006 | 247 | 0.050 |
Why?
|
| Insulin | 1 | 2009 | 1184 | 0.050 |
Why?
|
| Virus Replication | 1 | 2006 | 284 | 0.050 |
Why?
|
| Surface-Active Agents | 1 | 2004 | 57 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2000 | 663 | 0.050 |
Why?
|
| Swine | 1 | 2006 | 585 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2010 | 9070 | 0.050 |
Why?
|
| Receptor, IGF Type 2 | 1 | 2002 | 7 | 0.050 |
Why?
|
| Activin Receptors, Type I | 1 | 2002 | 13 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2002 | 102 | 0.050 |
Why?
|
| Osteoblasts | 1 | 2003 | 96 | 0.050 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2002 | 51 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2002 | 66 | 0.050 |
Why?
|
| Random Allocation | 1 | 2002 | 308 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2002 | 102 | 0.050 |
Why?
|
| Phosphatidylinositol Diacylglycerol-Lyase | 3 | 1997 | 7 | 0.050 |
Why?
|
| Cell Count | 1 | 2002 | 195 | 0.050 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2002 | 86 | 0.050 |
Why?
|
| Biopsy, Needle | 1 | 2002 | 226 | 0.050 |
Why?
|
| Food, Organic | 1 | 2001 | 3 | 0.040 |
Why?
|
| Psychology, Social | 1 | 2001 | 8 | 0.040 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2000 | 7 | 0.040 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2000 | 42 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 888 | 0.040 |
Why?
|
| Membrane Proteins | 3 | 2010 | 1260 | 0.040 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2000 | 145 | 0.040 |
Why?
|
| Phosphoinositide Phospholipase C | 2 | 1997 | 6 | 0.040 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 1999 | 10 | 0.040 |
Why?
|
| In Vitro Techniques | 2 | 1998 | 944 | 0.040 |
Why?
|
| Guanine | 1 | 1999 | 194 | 0.040 |
Why?
|
| Young Adult | 1 | 2011 | 6922 | 0.040 |
Why?
|
| Protein Kinase C-alpha | 4 | 1999 | 29 | 0.040 |
Why?
|
| Caspases | 2 | 2012 | 151 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 1909 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 3450 | 0.030 |
Why?
|
| Incidence | 1 | 2002 | 1697 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2000 | 409 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2013 | 1581 | 0.030 |
Why?
|
| Phospholipase C gamma | 1 | 1997 | 14 | 0.030 |
Why?
|
| Cell Membrane | 3 | 1998 | 661 | 0.030 |
Why?
|
| Tyrosine | 1 | 1997 | 131 | 0.030 |
Why?
|
| Neoplasms | 1 | 2012 | 3168 | 0.030 |
Why?
|
| Enzyme Induction | 2 | 2012 | 83 | 0.030 |
Why?
|
| Cholic Acids | 1 | 1995 | 7 | 0.030 |
Why?
|
| Cell Movement | 2 | 2011 | 804 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 885 | 0.030 |
Why?
|
| Piroxicam | 1 | 1995 | 11 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 1995 | 152 | 0.030 |
Why?
|
| Intestines | 1 | 1998 | 433 | 0.030 |
Why?
|
| Gastrointestinal Hormones | 1 | 1994 | 8 | 0.030 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 1994 | 27 | 0.030 |
Why?
|
| Quinuclidinyl Benzilate | 1 | 1994 | 2 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 1994 | 166 | 0.030 |
Why?
|
| Zanthoxylum | 1 | 2014 | 9 | 0.030 |
Why?
|
| Zingiberaceae | 1 | 2014 | 10 | 0.030 |
Why?
|
| Receptors, Muscarinic | 1 | 1994 | 42 | 0.030 |
Why?
|
| Metal Nanoparticles | 1 | 2014 | 35 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2014 | 85 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1994 | 287 | 0.030 |
Why?
|
| Jejunum | 1 | 2014 | 76 | 0.030 |
Why?
|
| CD3 Complex | 1 | 2014 | 135 | 0.030 |
Why?
|
| Vitamin D Deficiency | 1 | 1995 | 107 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2014 | 88 | 0.030 |
Why?
|
| Protein Kinases | 1 | 1995 | 210 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2014 | 68 | 0.030 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2013 | 16 | 0.030 |
Why?
|
| Biosensing Techniques | 1 | 2014 | 81 | 0.020 |
Why?
|
| Administration, Oral | 2 | 2011 | 655 | 0.020 |
Why?
|
| Microsomes | 1 | 1993 | 32 | 0.020 |
Why?
|
| Adult | 2 | 2011 | 27849 | 0.020 |
Why?
|
| Thumb | 1 | 1993 | 27 | 0.020 |
Why?
|
| Membrane Fluidity | 1 | 1992 | 9 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2001 | 2787 | 0.020 |
Why?
|
| Vinblastine | 1 | 1992 | 84 | 0.020 |
Why?
|
| Daunorubicin | 1 | 1992 | 77 | 0.020 |
Why?
|
| Evans Blue | 1 | 1992 | 3 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2009 | 1910 | 0.020 |
Why?
|
| Rats, Inbred SHR | 1 | 1992 | 33 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 201 | 0.020 |
Why?
|
| Rats, Inbred WKY | 1 | 1992 | 31 | 0.020 |
Why?
|
| Arteries | 1 | 1993 | 170 | 0.020 |
Why?
|
| Mucin-2 | 1 | 2012 | 12 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 290 | 0.020 |
Why?
|
| Caveolin 1 | 1 | 2012 | 24 | 0.020 |
Why?
|
| Microvessels | 1 | 2012 | 68 | 0.020 |
Why?
|
| Mucin-1 | 1 | 2012 | 46 | 0.020 |
Why?
|
| Drug Resistance | 1 | 1992 | 231 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2012 | 89 | 0.020 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2012 | 32 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2012 | 67 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 1995 | 537 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 1992 | 121 | 0.020 |
Why?
|
| Hydrogen Bonding | 1 | 2012 | 154 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 502 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2012 | 162 | 0.020 |
Why?
|
| Chitinase-3-Like Protein 1 | 1 | 2011 | 9 | 0.020 |
Why?
|
| Organ Specificity | 1 | 1992 | 279 | 0.020 |
Why?
|
| Maleimides | 2 | 2003 | 26 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2011 | 88 | 0.020 |
Why?
|
| Interleukin-17 | 1 | 2012 | 109 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2012 | 124 | 0.020 |
Why?
|
| Estradiol | 1 | 2012 | 247 | 0.020 |
Why?
|
| Peptides | 1 | 1994 | 653 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2012 | 177 | 0.020 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2011 | 45 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 291 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2012 | 276 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 448 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 1992 | 443 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2011 | 187 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2012 | 459 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2012 | 515 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2011 | 302 | 0.020 |
Why?
|
| Traction | 1 | 1989 | 8 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2010 | 336 | 0.020 |
Why?
|
| Indoles | 2 | 2003 | 298 | 0.020 |
Why?
|
| Binding Sites | 1 | 2012 | 1126 | 0.020 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1989 | 30 | 0.020 |
Why?
|
| Proteins | 1 | 2014 | 790 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 2010 | 233 | 0.020 |
Why?
|
| Protein Kinase C beta | 2 | 1999 | 13 | 0.020 |
Why?
|
| DNA | 1 | 2014 | 1260 | 0.020 |
Why?
|
| Immunoblotting | 1 | 1989 | 273 | 0.020 |
Why?
|
| Myosins | 1 | 1989 | 86 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2009 | 275 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1988 | 300 | 0.020 |
Why?
|
| Membrane Lipids | 1 | 1988 | 40 | 0.020 |
Why?
|
| Adolescent | 1 | 2001 | 9550 | 0.020 |
Why?
|
| Protein Binding | 1 | 2012 | 1526 | 0.020 |
Why?
|
| Liposomes | 1 | 1988 | 95 | 0.020 |
Why?
|
| Equipment Design | 1 | 1989 | 411 | 0.020 |
Why?
|
| Liver | 1 | 1992 | 1206 | 0.020 |
Why?
|
| Postoperative Care | 1 | 1989 | 232 | 0.020 |
Why?
|
| Lysosomes | 1 | 2008 | 123 | 0.020 |
Why?
|
| Ulcer | 1 | 2007 | 38 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2012 | 1120 | 0.020 |
Why?
|
| Permeability | 1 | 2007 | 143 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2007 | 115 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 1995 | 1980 | 0.020 |
Why?
|
| Homeostasis | 1 | 2009 | 459 | 0.020 |
Why?
|
| RNA Interference | 1 | 2007 | 379 | 0.020 |
Why?
|
| Contrast Media | 1 | 2010 | 986 | 0.010 |
Why?
|
| Wound Healing | 1 | 2007 | 372 | 0.010 |
Why?
|
| Substrate Specificity | 2 | 1998 | 361 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2008 | 443 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1988 | 660 | 0.010 |
Why?
|
| Cytokines | 1 | 2009 | 862 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2004 | 121 | 0.010 |
Why?
|
| Enterotoxins | 2 | 1994 | 22 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2004 | 161 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2010 | 773 | 0.010 |
Why?
|
| Bacterial Toxins | 2 | 1994 | 112 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2010 | 1269 | 0.010 |
Why?
|
| Escherichia coli Proteins | 2 | 1994 | 179 | 0.010 |
Why?
|
| Water | 1 | 2004 | 306 | 0.010 |
Why?
|
| Adenosine Triphosphate | 2 | 1994 | 312 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2001 | 65 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2000 | 35 | 0.010 |
Why?
|
| Zinc | 1 | 2001 | 97 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2000 | 33 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1999 | 26 | 0.010 |
Why?
|
| Curcumin | 1 | 1999 | 16 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1999 | 33 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 66 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 1999 | 75 | 0.010 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2000 | 184 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 1999 | 98 | 0.010 |
Why?
|
| Ionomycin | 1 | 1999 | 19 | 0.010 |
Why?
|
| Carbazoles | 1 | 1999 | 31 | 0.010 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 1999 | 16 | 0.010 |
Why?
|
| RNA | 1 | 2003 | 574 | 0.010 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 1999 | 87 | 0.010 |
Why?
|
| Cell Survival | 1 | 2000 | 1002 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1999 | 981 | 0.010 |
Why?
|
| Isoelectric Point | 1 | 1995 | 12 | 0.010 |
Why?
|
| Okadaic Acid | 1 | 1995 | 10 | 0.010 |
Why?
|
| Ethers, Cyclic | 1 | 1995 | 8 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1995 | 50 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1995 | 58 | 0.010 |
Why?
|
| Estrenes | 1 | 1994 | 7 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1995 | 279 | 0.010 |
Why?
|
| Pyrrolidinones | 1 | 1994 | 15 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 1989 | 10128 | 0.010 |
Why?
|
| Terpenes | 1 | 1994 | 18 | 0.010 |
Why?
|
| Natriuretic Peptides | 1 | 1994 | 7 | 0.010 |
Why?
|
| Thapsigargin | 1 | 1994 | 55 | 0.010 |
Why?
|
| Staurosporine | 1 | 1994 | 34 | 0.010 |
Why?
|
| Alkaloids | 1 | 1994 | 47 | 0.010 |
Why?
|
| Pirenzepine | 1 | 1994 | 6 | 0.010 |
Why?
|
| Diamines | 1 | 1994 | 9 | 0.010 |
Why?
|
| Parasympatholytics | 1 | 1994 | 17 | 0.010 |
Why?
|
| Atropine | 1 | 1994 | 53 | 0.010 |
Why?
|
| ras Proteins | 1 | 1995 | 132 | 0.010 |
Why?
|
| Nutritional Status | 1 | 1994 | 79 | 0.010 |
Why?
|
| Muscarinic Antagonists | 1 | 1994 | 59 | 0.010 |
Why?
|
| Alamethicin | 1 | 1993 | 1 | 0.010 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 1993 | 8 | 0.010 |
Why?
|
| Guanine Nucleotides | 1 | 1993 | 13 | 0.010 |
Why?
|
| Phosphatidylinositols | 1 | 1993 | 18 | 0.010 |
Why?
|
| Cations, Divalent | 1 | 1993 | 34 | 0.010 |
Why?
|
| Adenine Nucleotides | 1 | 1993 | 57 | 0.010 |
Why?
|
| Stearates | 1 | 1992 | 1 | 0.010 |
Why?
|
| Benzyl Alcohols | 1 | 1992 | 2 | 0.010 |
Why?
|
| Benzyl Alcohol | 1 | 1992 | 3 | 0.010 |
Why?
|
| Piperidines | 1 | 1994 | 163 | 0.010 |
Why?
|
| Bile Acids and Salts | 1 | 1993 | 77 | 0.010 |
Why?
|
| Microsurgery | 1 | 1993 | 100 | 0.010 |
Why?
|
| Biological Transport | 1 | 1992 | 398 | 0.010 |
Why?
|
| Aged | 1 | 2002 | 20395 | 0.000 |
Why?
|